Whereas our results agree with the observed blocking effect of type I IFNs on the IL-17 production by human PBMCs47, 48, 49, 50, IFNα treatment of such cells from SLE patients induced IL-17 secretion, which was positively correlated with BLyS release. This evidence concerns the gene IFNA2 and systemic lupus erythematosus.